Human immunodeficiency virus 1 (HIV-1) is a complex retrovirus that employs genetic and cell biological strategies not known to be associated with simple retroviruses. Two of these strategies involve adept use of the host cell's nuclear transport apparatus. In one case, the HIV-1 Rev protein exercises control over RNA export during virus replication [1, 2] , and in the second case viral proteins, including the matrix protein (MA), direct the nuclear import of the viral preintegration complex during infection. The precise mechanism by which the MA protein directs nuclear transport of the viral genome will be difficult to ascertain, because its action is inextricably linked to subtle features of the viral membrane and internal structure, which change during maturation and along the intracellular pathway of infection.
As was first shown for visna virus [3] , HIV-1 and the other lentiviruses can infect both dividing and non-dividing cells [4, 5] . During the course of infecting non-dividing cells, the HIV-1 preintegration complex is actively transported across the intact interphase nuclear envelope [6] . The nuclear import of HIV-1 preintegration complexes was found to be inhibitable during infection by the addition of synthetic nuclear localization signal (NLS) peptides derived from simian virus 40 (SV40) large Tantigen to the tissue culture cell medium [7] . This observation suggests that the HIV-1 preintegration complex is imported via the cell's predominant transport pathway, and that it must compete with cellular nuclear traffic for saturable transport factors [8] .
In contrast to the lentiviruses, the oncoretrovirus murine leukemia virus (MuLV) is unable to infect non-dividing cells [6, 9] . The favoured hypothesis to explain this replication barrier is that the MuLV preintegration complex lacks functional NLSs, and thus depends on a mitotic cycle of nuclear envelope breakdown and assembly to gain access to the host genome [6, 9] . Because there is considerable diversity among oncoretroviruses, it is possible that some non-lentiviruses produce karyophilic (nucleusseeking) preintegration complexes that are blocked after nuclear transport, for example, prior to integration. Sadly, though, it is the capacity of HIV-1 to integrate and replicate in non-dividing cells that leads to infections of terminally differentiated macrophages and neuroglia cells, defining events in the unique pathology of human AIDS.
In the past two years, significant advances have been made in our understanding of HIV-1 nuclear transport. Most recently, Gallay et al. [10] have proposed that phosphorylation of the 17kD MA protein plays a key role in the establishment of the karyophilic HIV-1 preintegration complex. The MA proteins of both simple and complex retroviruses, which are initially translated as polyproteins encoded by the viral gag gene, are closely associated with the viral membrane -thousands of MA polypeptides are anchored in the inner leaflet of the viral membrane by amino-terminal myristoyl groups. On the face of it, this membrane association is difficult to reconcile with MA having a role in the nuclear transport of the membrane-free HIV-1 preintegration complex.
MA is essential for the assembly of nascent HIV-1 virions, but it was thought that this requirement was attributable to its roles in targeting the rest of the gag polyprotein to the membrane before its release by proteolytic processing, and in recruiting the envelope glycoprotein (Gp120 and Gp41) to the plasma membrane. Immunogold electron microscopic analysis indicated that MA covers the spherical interior surface of the viral membrane, whereas the core-associated protein (CA), which dissociates prior to formation of the preintegration complex, coats the triangular shell of the core particle [11] . Furthermore, the bulk of MA is always recovered from cytoplasmic membrane fractions (see [10] ). It was thus surprising to learn that HIV-1 preintegration complexes that fractionated from cell extracts with nuclei contained some MA in addition to the viral genome, reverse transcriptase and integrase [12] . A model for the role of MA in the nuclear transport of the HIV-1 preintegration complex during infection is shown in Figure 1 .
The earliest indication that MA directly participates in the nuclear transport of the HIV-1 preintegration complex came from studies showing, first, that MA contains an NLS capable of targeting microinjected reporter proteins to the nuclei of tissue culture cells [13] , and, second, that viruses with mutations of the MA NLS can be propagated in dividing cells but not in cell-cycle-arrested cells [13, 14] . The latter studies used HIV-1 strains that lacked the auxiliary gene, vpr. Subsequently, it was shown that the Vpr protein itself contains an NLS that is sufficient for HIV-1 import in an HIV-1 strain containing a defective MA NLS [15] . Thus, MA and Vpr contain redundant NLSs that are sufficient but not necessary for HIV-1 nuclear transport. The vpr gene is not, however, essential for infection, replication or the development of AIDS in rhesus monkeys infected with SIV [16] , and a number of the studies on HIV-1 nuclear transport use infectious HIV-1 strains lacking a vpr gene. It remains to be seen whether other proteins of the HIV-1 preintegration complex contain NLSs that fractionally stimulate the rate of nuclear transport. These initial studies left unresolved the intriguing question of how MA can both comprise a major part of the viral membrane and direct the nuclear transport of the membrane-free preintegration complex.
This dilemma was recently addressed by Gallay et al.
[101, who first confirmed that a subset of MA molecules contain phosphoserine and phosphotyrosine, and went on to show that it is this population of MA proteins that is imported into nuclei during infection. Interestingly, the MA proteins in this population also contained myristoyl groups, suggesting that they had at one time been attached to the membrane. Previous studies on other myristoylated proteins, showing that they could be released from the plasma membrane following phosphorylation [17, 18] , provided the rationale for the hypothesis that phosphorylation of MA triggers its transfer from the membrane to the maturing core during virus assembly (Fig. 2) . This hypothesis predicts that, during virus assembly, -1 % of MA polypeptides are transferred into the core particle, while the remaining -99 % remain associated with the incipient viral membrane.
To investigate the role of MA tyrosine phosphorylation in this partitioning process, Gallay et al. [10] systematically substituted the three MA tyrosines (Y) with phenylalanines (F), and tested the effects of the mutations on the production of infectious virus particles. The results showed that tyrosine residue Y132 is the target of a putative cellular kinase. MA tyrosine phosphorylation occurred in the absence of other viral proteins, but only if MA was anchored to the plasma membrane either by its myristoyl group or by fusion to the cytoplasmic domain of CD4 (the plasma membrane receptor for HIV-1). This result, together with the observation that nuclear MA contains phosphotyrosine, supports the hypothesis that the MA-gag polyprotein is first inserted into the plasma membrane, proteolytically processed, phosphorylated, and only then transferred to the core.
The association of NLS-containing MA proteins with what will develop into the preintegration complex during subsequent infections is thus established during virus maturation. Although tyrosine phosphorylation of MA correlates with its nuclear transport, and MA was previously shown to be associated with nuclear forms of the preintegration complex [12] , the physical association of MA with the core particle in the mature virus is so far only implied, not proven. Curiously, Gallay et al. [10] find tyrosine kinase activity associated with mature virus. Whether this kinase is merely trapped in the virus after MA transfer is completed, or, alternatively, continues to act on MA within the mature virus not known.
The model illustrated in Figure 1 predicts that MA transfer is dependent on tyrosine phosphorylation and that, in the absence of phosphorylation, the inchoate preintegration complex will not receive the complement of MA NLSs it needs to cross the nuclear envelope. In fact, mutant virus with the Y132F MA mutation could be propagated in dividing cells, but not in non-dividing cells. This result shows that Y132 phosphorylation is required for the formation of a potent karyophilic HIV-1 preintegration complex. But while the Y132F mutation completely inhibited replication of the virus in non-dividing cells, the absence of tyrosine phosphorylation did not completely abolish the formation of viral DNA circles that occurs only after import of the preintegration complex into the nucleus. It is conceivable that, in the absence of Y132 phosphorylation, a small number of MA proteins are still transferred into the maturing core, and these are sufficient to support a limited degree of nuclear transport in non-dividing cells, but not enough for the virus to mount a productive infection.
Gallay et al. [10] point out that serine phosphorylation of MA, which persists in the Y132F mutant, could promote the transfer of a few MA proteins to the viral core. The relative contributions of tyrosine and serine phosphorylation of MA to its function in nuclear import are key to our understanding of how HIV-1 infects non-dividing cells. Future studies of the metabolism of MA during virus assembly will have to focus attention directly on the role of MA serine phosphorylation. Once all the factors that contribute to MA transfer are known, the next question will be the nature and timing of the regulatory mechanism that determines how many molecules of MA are transferred from the membrane to the core. These issues, and those pertaining to the disposition of the myristoyl group and the MA NLS in the karyophilic preintegration complex, will be addressed by biochemical studies of viral core particles and cytoplasmic preintegration complexes. Now that several basic features of the molecular mechanism of HIV-1 nuclear transport have been revealed, broader questions about the role of viral nuclear transport in the development of AIDS pathology, viral latency and rates of propagation can be investigated. Future research will have to focus on HIV-1 nuclear transport in animal models, where assessments of host invasion and the establishment of the virus in different tissues can be made under physiological conditions. Lastly, these insights into the mechanism of HIV-1 nuclear transport, together with the curious observation that synthetic NLS peptides can inhibit HIV-1 replication in growth-arrested tissue culture cells by interfering with its nuclear transport [7] , suggest that the nuclear transport of HIV-1 may be a viable target of future vaccines and anti-HIV-1 drugs [19] .
